Table 6.
Percentages of absence of SCR at follow-up
No SCR at end of follow-up, n/total (%) | P value∗ | |
---|---|---|
HbSS/HbSβ0/HbSβ+ | 51 of 83 (61.4) | .025 |
Male | 19 of 39 (48.7) | |
Female | 32 of 44 (72.7) | |
HbSC | 14 of 46 (30.4) | .177 |
Male | 4 of 20 (20) | |
Female | 10 of 26 (38.5) |
Pearson χ2.